Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 3
1963 4
1964 5
1965 5
1966 7
1967 6
1968 9
1969 4
1970 5
1971 3
1972 2
1973 1
1974 3
1975 5
1976 3
1977 4
1978 3
1979 3
1980 6
1981 12
1982 8
1983 8
1984 9
1985 7
1986 9
1987 12
1988 12
1989 30
1990 24
1991 21
1992 18
1993 26
1994 24
1995 14
1996 17
1997 35
1998 32
1999 28
2000 28
2001 29
2002 28
2003 36
2004 33
2005 53
2006 46
2007 53
2008 60
2009 58
2010 53
2011 61
2012 81
2013 85
2014 67
2015 75
2016 81
2017 81
2018 83
2019 103
2020 98
2021 101
2022 115
2023 135
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

1,898 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Brunet M, et al. Among authors: masuda s. Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640. Ther Drug Monit. 2019. PMID: 31045868 Review.
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer.
Kitajima S, Ivanova E, Guo S, Yoshida R, Campisi M, Sundararaman SK, Tange S, Mitsuishi Y, Thai TC, Masuda S, Piel BP, Sholl LM, Kirschmeier PT, Paweletz CP, Watanabe H, Yajima M, Barbie DA. Kitajima S, et al. Among authors: masuda s. Cancer Discov. 2019 Jan;9(1):34-45. doi: 10.1158/2159-8290.CD-18-0689. Epub 2018 Oct 8. Cancer Discov. 2019. PMID: 30297358 Free PMC article.
The endothelial Dll4-muscular Notch2 axis regulates skeletal muscle mass.
Fujimaki S, Matsumoto T, Muramatsu M, Nagahisa H, Horii N, Seko D, Masuda S, Wang X, Asakura Y, Takahashi Y, Miyamoto Y, Usuki S, Yasunaga KI, Kamei Y, Nishinakamura R, Minami T, Fukuda T, Asakura A, Ono Y. Fujimaki S, et al. Among authors: masuda s. Nat Metab. 2022 Feb;4(2):180-189. doi: 10.1038/s42255-022-00533-9. Epub 2022 Feb 28. Nat Metab. 2022. PMID: 35228746
Fast-forward scaling theory.
Masuda S, Nakamura K. Masuda S, et al. Philos Trans A Math Phys Eng Sci. 2022 Dec 26;380(2239):20210278. doi: 10.1098/rsta.2021.0278. Epub 2022 Nov 7. Philos Trans A Math Phys Eng Sci. 2022. PMID: 36335946 Free PMC article. Review.
Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19.
Lemaitre F, Budde K, Van Gelder T, Bergan S, Lawson R, Noceti O, Venkataramanan R, Elens L, Moes DJAR, Hesselink DA, Pawinski T, Johnson-Davis KL, De Winter BCM, Pattanaik S, Brunet M, Masuda S, Langman LJ. Lemaitre F, et al. Among authors: masuda s. Ther Drug Monit. 2023 Apr 1;45(2):191-199. doi: 10.1097/FTD.0000000000001014. Ther Drug Monit. 2023. PMID: 35944126 Free article.
Comprehensive review on small common bile duct stones.
Masuda S, Koizumi K, Shionoya K, Jinushi R, Makazu M, Nishino T, Kimura K, Sumida C, Kubota J, Ichita C, Sasaki A, Kobayashi M, Kako M, Haruki U. Masuda S, et al. World J Gastroenterol. 2023 Apr 7;29(13):1955-1968. doi: 10.3748/wjg.v29.i13.1955. World J Gastroenterol. 2023. PMID: 37155530 Free PMC article. Review.
1,898 results